next glp 1 drug GLP-1 Agonists: A Comprehensive Overview Study predicts 16 new obesity
Description
Serena Williams says she has lost weight using GLP-1 medication
Yale Medicine experts explain who qualifies, who can prescribe, and what to expect.
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are emerging glucose-lowering agents primarily used in managing diabetes and obesity
Learn why they happen, which foods trigger them, and proven remedies to stop them.
Results Twenty-eight RCTs were ultimately included for analysis, involving a total of 77,485 participants
In clinical practice, drug selection should therefore prioritize factors such as tolerability, safety profile, adherence, cost, and patient preference rather than expecting major differences in cardiovascular efficacy.
